Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
NCT02930850 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 447
Last updated 2019-04-08
Summary
The purpose study is to report on the accuracy of noninvasive hemoglobin (SpHb) as compared to hemoglobin measurements obtained from a laboratory hematology analyzer.
Conditions
- Anemia
- Healthy
- Pediatric ALL
Interventions
- DEVICE
-
Rad-67 Pulse oximeter
Noninvasive pulse oximeter that measures hemoglobin
Sponsors & Collaborators
-
Masimo Corporation
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Month
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-09-30
- Primary Completion
- 2016-10-31
- Completion
- 2016-10-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening Anemia
NCT01881503 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT06238544 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
BioRBC Survival in Adults With Prior Antibody Response to BioRBCs
NCT02077751 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Efficacy and Safety of BGE-117 in the Treatment of Anemia of Aging
NCT04815603 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effects of Intravenous Injection of Erythropoietin on Hepcidin Pharmacokinetics in Healthy Volunteers
NCT00687518 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
NCT02075463 ·Status: TERMINATED ·Phase: PHASE2
-
STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) Patients
NCT00364845 ·Status: TERMINATED ·Phase: PHASE3
-
Validation of a Smartphone App for Anemia Screening Among General Population
NCT05490823 ·Status: UNKNOWN ·Phase: NA
-
A Study to Determine the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia Caused by Advanced Cancer
NCT00269984 ·Status: COMPLETED ·Phase: PHASE2
-
Validation of a New Standardized Clinical Anemia Evaluation Score Using a Hb Visual Scale in Nephrological Patients
NCT00478582 ·Status: COMPLETED ·Phase: NA
-
Proof of Concept Study to Assess the Efficacy, Safety of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT06051357 ·Status: COMPLETED ·Phase: PHASE2
-
Practical Anemia Bundle for SusTained Blood Recovery
NCT05167734 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Feasibility Study of a Novel Non-invasive Device for Diagnosis of Anemia
NCT06159348 ·Status: COMPLETED
-
A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of APG-5918.
NCT05773586 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)
NCT01977573 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Intravenous Iron Repletion on Renal Function in Patients With Iron Deficiency and Acute Kidney Injury
NCT05960227 ·Status: COMPLETED ·Phase: PHASE2
-
The Impact of Red Cell Age on Product Utilization in the Chronically Transfused Outpatient Population
NCT02393508 ·Status: UNKNOWN ·Phase: PHASE3
-
Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & Anemia
NCT00086086 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
NCT05876312 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-
NCT01964196 ·Status: COMPLETED ·Phase: PHASE2
-
Early Administration of Recombinant Erythropoietin (RHEPO) in Transfusion Savings in Trauma Patients
NCT03867071 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia
NCT01977482 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase Ib, Multicenter, Open-Label Study of Multiple-Dose EA5 in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT07256301 ·Status: RECRUITING ·Phase: PHASE1
-
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)
NCT03409107 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia
NCT07075484 ·Status: COMPLETED ·Phase: PHASE1